Results 1 to 10 of about 258,864 (309)
Clinical Journal of the American Society of Nephrology, 2019 In general, nephrologists give little thought to contraception, leaving this task to other practitioners, but the significant risks associated with drugs routinely prescribed to treat kidney disease; the potential for pregnancy-associated adverse outcomes in women with CKD; and the effect ...
Anna, Burgner, Michelle A, Hladunewich
openaire +2 more sources
Mechanisms and Treatment of CKD [PDF]
Journal of the American Society of Nephrology, 2012 As CKD continues to increase worldwide, along with the demand for related life-saving therapies, the financial burden of CKD will place an increasing drain on health care systems. Experimental studies showed that glomerular capillary hypertension and impaired sieving function with consequent protein overload play a pathogenic role in the progression of
P. Ruggenenti, P. Cravedi, G. Remuzzi
openaire +3 more sources
The Role of Bone Biopsy in the Management of CKD-MBD: CKD-Related Osteoporosis or CKD-MBD/Osteoporosis? [PDF]
Calcified Tissue International, 2021 info:eu-repo/semantics ...
Ana Carina Ferreira +3 more
openaire +4 more sources
CKD in Disadvantaged Populations [PDF]
Canadian Journal of Kidney Health and Disease, 2014 The increased burden of CKD in disadvantaged populations is due to both global factors and population-specific issues. Low socioeconomic status and poor access to care contribute to healthcare disparities and exacerbate the negative effects of genetic or biologic predisposition.
Guillermo Garcia-Garcia, Vivekanand Jha
openaire +19 more sources
Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
Frontiers in Endocrinology, 2022 IntroductionWhile it is well known that thyroid function may affect kidney function, the transition of the chronic kidney disease (CKD) status before and after treatment for thyroid disorders, as well as the factors affecting this change, remains to be explored.
Uchiyama-Matsuoka, Natsumi +12 more
openaire +4 more sources
Scientific Reports, 2021 Despite advances in therapeutic strategies for multiple sclerosis (MS), the therapy options remain limited with various adverse effects. Here, the therapeutic potential of CKD-506, a novel HDAC6-selective inhibitor, against MS was evaluated in mice with ...
Daekwon Bae +10 more
doaj +1 more source
Bioavailability of the Common Cold Medicines in Jellies for Oral Administration
Pharmaceutics, 2020 Jellies for oral administration have been suggested as alternative dosage forms to conventional tablets for improved palatability and compliances for pediatric and geriatric patients.
Ki Hyun Kim, Minju Jun, Mi-Kyung Lee
doaj +1 more source
Journal of Nepal Medical Association, 2021 Introduction: Chronic Kidney Disease is an independent risk factor for pneumonia. The risk of hospitalization, Intensive Care Unit and ventilator requirement, in-hospital death is high in pneumonia patients with chronic kidney disease. This study aims to
Abhishek Pant +5 more
doaj +1 more source
Canadian Journal of Kidney Health and Disease, 2021 Purpose of program: Integrated knowledge translation (IKT) is a collaborative approach whereby knowledge created through health research is utilized in ways that are relevant to the needs of all stakeholders. However, research teams have limited capacity
Meghan J. Elliott +13 more
doaj +1 more source
Arthritis Research & Therapy, 2020 Objectives Histone deacetylase (HDAC) 6 promotes inflammation. We investigated the anti-arthritic effects of CKD-506, a novel HDAC6 inhibitor, in vitro and in a murine model of arthritis as a novel treatment option for rheumatoid arthritis (RA).
Jin Kyun Park +11 more
doaj +1 more source